Search Results - "Schizophrenia"

Long‐acting injectable antipsychotics as maintenance therapy for schizophrenia during the COVID‐19 pandemic: A micro‐narrative review by Yoshiyo Oguchi, Nobumi Miyake, Kumiko Ando

Connect to this object online.

Effects of low-dose combined olanzapine and sertraline on negative and depressive symptoms in treatment-resistant outpatients with acute exacerbated schizophrenia by Xiaoe Lang, Xiaocui Zang, Feng Yu, Meihong Xiu

Connect to this object online.

Diagnostic specificity of the child psychosis-risk screening system with a focus on the differentiation of schizophrenia spectrum disorders and neurodevelopmental disorders by Yukiko Hamasaki, Yukiko Hamasaki, Yuko Sakaue, Masahiro Matsuo, Riku Sanada, Takao Nakayama, Shugo Michikoshi, Satoko Ueba, Naoki Kurimoto, Naoki Kurimoto, Takatoshi Hikida, Toshiya Murai

Connect to this object online.

The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and Review by Alessandro Cuomo, Giuseppe Maina, Gianluca Rosso, Bruno Beccarini Crescenzi, Simone Bolognesi, Angela Di Muro, Nicola Giordano, Arianna Goracci, Stephen M. Neal, Maria Nitti, Fulvio Pieraccini, Andrea Fagiolini

Connect to this object online.

Cognitive and negative symptoms in schizophrenia with L‐Carnosine adjuvant therapy - A randomized double‐blind placebo‐controlled study by Hema Tharoor, Sindhu Maran, Antra K. Chandan, Manikandan Pari, Shruti Rao, Jothilakshmi Durairaj

Connect to this object online.

SlgA, encoded by the homolog of the human schizophrenia-associated gene PRODH, acts in clock neurons to regulate Drosophila aggression by Liesbeth Zwarts, Veerle Vulsteke, Edgar Buhl, James J. L. Hodge, Patrick Callaerts

Connect to this object online.

Nicotine, auditory sensory memory and attention in a human ketamine model of schizophrenia: moderating influence of a hallucinatory trait by Verner eKnott, Verner eKnott, Verner eKnott, Verner eKnott, Verner eKnott, Dhrasti eShah, Anne eMillar, Judy eMcIntosh, Derek eFisher, Crystal eVilleneuve, Vadim eIlivitsky

Connect to this object online.

Real-World Adherence and Discontinuation of Oral Antipsychotics and Associated Factors in a National Sample of US Medicare Beneficiaries with Schizophrenia by Zacker C, Puckett JT, Kamal-Bahl S

Connect to this object online.

Evaluation of Mucoadhesive Nano-Bilosomal In Situ Gels Containing Anti-Psychotic Clozapine for Treatment of Schizophrenia: In Vitro and In Vivo Studies by Marwa H. Abdallah, Mona M. Shahien, Hemat El-Sa, Enas Haridy Ahmed, Hanan M. El-Nahas, Nourhan A. Abdulla, Tarek M. Ibrahim

Connect to this object online.

Effectiveness of social skill program for social performance among schizophrenia patients selected tertiary care Hospital, Coimbatore. India by M. Baskaran, G. Raghuthaman, A. Jayasudha

Connect to this object online.

Gamma‐band harmonic responses for beta‐band auditory steady‐state response are intact in patients with early stage schizophrenia by Mariko Tada, Kenji Kirihara, Tatsuya Nagai, Shinsuke Koike, Tsuyoshi Araki, Kiyoto Kasai

Connect to this object online.

Identifying Unique Subgroups of High-Cost Patients With Schizophrenia: A Population-Based Study Using Latent Class Analysis by Andrew J Stewart, Scott B Patten, Kirsten M Fiest, Tyler S Williamson, James P Wick, Paul E Ronksley

Connect to this object online.

Sarcosine May Induce EGF Production or Inhibit the Decline in EGF Concentrations in Patients with Chronic Schizophrenia (Results of the PULSAR Study) by Agnieszka Pawlak, Bartosz Kaczmarek, Adam Wysokiński, Dominik Strzelecki

Connect to this object online.

Corrigendum: Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients by Jing Huang, Jing Huang, Jing Huang, Gang-Rui Hei, Gang-Rui Hei, Gang-Rui Hei, Ye Yang, Ye Yang, Ye Yang, Chen-Chen Liu, Chen-Chen Liu, Chen-Chen Liu, Jing-Mei Xiao, Jing-Mei Xiao, Jing-Mei Xiao, Yu-Jun Long, Yu-Jun Long, Yu-Jun Long, Xing-Jie Peng, Xing-Jie Peng, Xing-Jie Peng, Yi Yang, Jing-Ping Zhao, Jing-Ping Zhao, Jing-Ping Zhao, Ren-Rong Wu, Ren-Rong Wu, Ren-Rong Wu, Ren-Rong Wu

Connect to this object online.

Adherence to a guided walking program with amelioration of cognitive functions in subjects with schizophrenia even during COVID-19 pandemic by S. Mandini, M. Morelli, M. Belvederi Murri, L. Grassi, S. Masotti, L. Simani, V. Zerbini, A. Raisi, T. Piva, G. Grazzi, G. Mazzoni

Connect to this object online.

Comparative analysis of antipsychotic drug consumption for inpatient schizophrenia treatment: a retrospective study with 5-year follow-up by L. B. Vaskova, M. V. Tiapkina, E. V. Mikhaylenko

Connect to this object online.

Factors associated with high‐dose antipsychotic prescriptions in outpatients with schizophrenia: An analysis of claims data from a Japanese prefecture by Tatsuichiro Takahashi, Tetsuya Otsubo, Susumu Kunisawa, Noriko Sasaki, Yuichi Imanaka

Connect to this object online.

Efficacy and safety of intermittent theta-burst stimulation in patients with schizophrenia: A meta-analysis of randomized sham-controlled trials by Kah Kheng Goh, Kah Kheng Goh, Kah Kheng Goh, Chun-Hsin Chen, Chun-Hsin Chen, Chun-Hsin Chen, Tzu-Hua Wu, Tzu-Hua Wu, Yi-Hang Chiu, Yi-Hang Chiu, Mong-Liang Lu, Mong-Liang Lu, Mong-Liang Lu

Connect to this object online.

A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia by Diana Z. Osmanova, Maxim B. Freidin, Olga Yu. Fedorenko, Ivan V. Pozhidaev, Anastasiia S. Boiko, Natalia M. Vyalova, Vladimir V. Tiguntsev, Elena G. Kornetova, Anton J. M. Loonen, Arkadiy V. Semke, Bob Wilffert, Nikolay A. Bokhan, Svetlana A. Ivanova

Connect to this object online.

Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case-control study by Kao Wei-Tsung, Shu Bih-Ching, Lung For-Wey, Chen C Nathan, Ku Yu-Chi, Tzeng Dong-Sheng

Connect to this object online.